Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Qingdao
Clinical trial register · China

Clinical Trials in Qingdao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Qingdao 32 Weifang 3 Yantai 3 Weihai 2 Rizhao 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The Affiliated Hospital of Qingdao University32 Tianjin Medical University17 Qilu Hospital of Shandong University8 Qingdao Central Hospital6 Alexion Pharmaceuticals, Inc.3 Clear sponsor filter
Site location
Qingdao32 Weifang3 Yantai3 Weihai2 Rizhao2
All 11 locations
Target enrolment
to

Trials with a site in Qingdao

32 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
The Affiliated Hospital of Qingdao University
Not applicable
150
Qingdao
2026-10-02
Not yet open
The Affiliated Hospital of Qingdao University
Observational
200
Qingdao
2026-08-20
Not yet open
The Affiliated Hospital of Qingdao University
Not applicable
328
Qingdao
2026-08-01
Not yet open
Multimodal Prehabilitation for Tumor-Related Bowel Obstruction
NCT07767760Malignant Tumor, Prehabilitation
The Affiliated Hospital of Qingdao University
Not applicable
394
Qingdao
2026-08-01
Recruiting
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
NCT07714980Gastric Cancer (GC), Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
300
Dongying, Qingdao, Rizhao, Weifang, Weihai, Yantai
2026-07-25
Not yet open
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
NCT07676266Multiple Sclerosis (MS), Myasthenia Gravis (MG), Neuromyelitis Optica Spectrum Disorder, Systemic Lupus Erythematosus
The Affiliated Hospital of Qingdao University
Phase 1
18
Qingdao
2026-07
Recruiting
The Affiliated Hospital of Qingdao University
Phase 4
294
Qingdao, Weifang
2026-05-22
Not yet open
The Affiliated Hospital of Qingdao University
Phase 4
20
Qingdao, Weihai, Yantai, Zibo
2026-05-01
Not yet open
The Affiliated Hospital of Qingdao University
Not applicable
18
Guangzhou, Qingdao, Tai’an, Chongqing
2026-03-05
Not yet open
The Affiliated Hospital of Qingdao University
Phase 1/2
9
Guangzhou, Qingdao, Tai’an, Chongqing
2026-02-28
Active, closed
The Affiliated Hospital of Qingdao University
Phase 1
28
Qingdao
2026-01-22
Not yet open
The Affiliated Hospital of Qingdao University
Phase 4
238
Qingdao
2025-10-31
Not yet open
The Affiliated Hospital of Qingdao University
Not applicable
90
Qingdao
2025-09-20
Recruiting
Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy
NCT07125586Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
The Affiliated Hospital of Qingdao University
Not applicable
353
Qingdao
2025-08-26
Recruiting
The Affiliated Hospital of Qingdao University
Not applicable
300
Qingdao
2025-08-01
Recruiting
Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction
NCT07130409Cardiac Magnetic Resonance Imaging, Acute Myocardial Infarction (AMI), PET / MR
The Affiliated Hospital of Qingdao University
Observational
20
Qingdao
2025-08
Recruiting
The Affiliated Hospital of Qingdao University
Observational
60
Qingdao
2025-07-30
Recruiting
The Affiliated Hospital of Qingdao University
Phase 2
35
Qingdao
2025-06-01
Recruiting
The Affiliated Hospital of Qingdao University
Observational
300
Qingdao
2025-05-14
Active, closed
Carina™ Surgical Platform for Minimal Radical Gastrectomy
NCT07113340Robotic Gastrectomy, Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
20
Qingdao
2025-05-01
Recruiting
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
NCT06916624Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC)
The Affiliated Hospital of Qingdao University
Observational
120
Qingdao
2025-04-12
Recruiting
The Affiliated Hospital of Qingdao University
Observational
30
Qingdao
2025-04-11
Recruiting
The Affiliated Hospital of Qingdao University
Observational
40
Qingdao
2025-04-09
Not yet open
The Affiliated Hospital of Qingdao University
Phase 1
32
Qingdao
2025-01-02
Recruiting
The Affiliated Hospital of Qingdao University
Phase 1
120
Qingdao
2024-12-04
Recruiting
TEAS for Gastrectomy Recovery
NCT07898293Gastric Cancer (GC), Stomach Neoplasms
The Affiliated Hospital of Qingdao University
Not applicable
104
Qingdao, Rizhao, Weifang, Yantai
2024-10-07
Active, closed
The Affiliated Hospital of Qingdao University
Observational
500
Qingdao
2024-06-01
Recruiting
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
NCT06544720Human Papillomavirus Associated Carcinomas, Cervical Cancer, Head and Neck Cancers, Anal Cancer
The Affiliated Hospital of Qingdao University
Phase 1
18
Qingdao
2023-08-02
Recruiting
The Affiliated Hospital of Qingdao University
Not applicable
588
Qingdao
2023-07-07
Recruiting
The Affiliated Hospital of Qingdao University
Phase 3
616
Qingdao
2022-11-20
Not yet open
The Affiliated Hospital of Qingdao University
Early Phase 1
10
Qingdao
2022-10-08
Active, closed
The Affiliated Hospital of Qingdao University
Not applicable
368
Qingdao
2022-09-01
Rows per page Showing 1–32 of 32
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/qingdao

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 32 of those studies with a site in Qingdao that also match the filters currently applied.

How many clinical trials are recruiting in Qingdao?

17 of the 32 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 11 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Qingdao), 32 studies
PhaseStudiesRecruitingShare
Not applicable12637.5%
Observational8625%
Phase 15215.6%
Phase 4319.4%
Early Phase 1103.1%
Phase 1/2103.1%
Phase 2113.1%
Phase 3113.1%

Most active sponsors

Lead sponsors with the most studies (Qingdao)
Lead sponsorStudiesRecruiting
The Affiliated Hospital of Qingdao University3217
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.